Publicador de contenidos

Back to 2014_05_28_CIMA_Presentación de la Beca Josefina Garre en Murcia

presentation of the scholarship Josefina Garre in Murcia

It is intended for the research that develops the CIMA on Huntington's disease.

Image description
PHOTO: Courtesy
28/05/14 18:57 Mª Pilar Huarte

The association Human Managementthe research center Applied Medical (CIMA) of the University of Navarra and the Hospital Universitario Virgen de Arrixaca, have celebrated in Murcia the public act of presentation of the "scholarship Josefina Garre for the research of neurodegenerative diseases: Alzheimer, Parkinson and Huntington", an important initiative that already has the support of different companies, institutions and media of the Region.

The event, held at the Cajamurcia Cultural classroom , was attended by more than two hundred people, including the Regional Minister of Health and Social Policy, Catalina Lorenzo, the Mayor of Torre Pacheco, Daniel Garcia, as well as numerous doctors, researchers and specialists in these diseases.

The event was inaugurated by the President of the Region of Murcia, Alberto Garre, who highlighted above all "the courage of the people who are leading the initiative and who are making the financial donations", encouraging all those present to internalize these problems and to support the people who suffer from them.

The President of Dirección Humana, Miguel Moreno, highlighted the convenience of companies joining this initiative, "and including it in their Corporate Social Responsibility Programs, being aware of the importance of bringing the medical health research closer to the business world".

The Director General of the Foundation for Applied Medical research (CIMA), Francisco Errasti, explained the great advances that the organization he directs is achieving, "thanks to which we are managing to find therapeutic solutions to the needs of the sick".

exhibition The event was attended by Carmen Antúnez, Director of the Dementias Unit of the Virgen de la Arrixaca University Hospital, and Alberto Pérez-Mediavilla, Associate Dean of the School of Pharmacy of the University of Navarra and Alzheimer's expert scientist, who gave a presentation on the current status of neurodegenerative diseases, as well as the advances in their biomedical research and their future forecast.

Isabel Pérez-Otaño, Director of the Neurosciences Program at the University of Navarra, also took part in the event, explaining the progress made in research into Huntington's disease, which has identified the molecule that causes the pathological elimination of neuronal connections in the disease (GluN3A molecule) "with which we have already demonstrated that, by suppressing this anomaly, we can correct the symptoms of the disease, which is undoubtedly a great advance".

Finally, Josefina Garre herself intervened, who presented the scholarship, aimed at investigating the disease she suffers from.

Josefina Garre, born 31 years ago in Torre Pacheco, was diagnosed with Huntington's disease for which there is currently no cure.

With a degree in Nutrition from the University of Navarra and a degree in Nursing from UCAM, she worked for several years as a nurse. Currently, limited by her illness, Josefina tries to maintain an active life "walking every day, playing the oboe and working as a volunteer at the file Municipal of her town".

Josefina Garre has donated her disability pension to the creation of the scholarship, which is also receiving financial support from family members, companies and individuals. "All these actions are meaning a way of approaching the disease in a positive way, and with the satisfaction of knowing that I am helping those who will come after me."

Huntington's disease is the most common neurodegenerative disease after Alzheimer's and Parkinson's. It is hereditary and characterized by the appearance of involuntary and uncontrolled movements. It is hereditary and is characterized by the appearance of involuntary and uncontrolled movements. In advanced stages, it causes severe motor and cognitive impairment, psychiatric disorders and dementia. Although the mutation Genetics manager of the disease was discovered 20 years ago, the mechanisms that cause the loss of connections and neuronal death are unknown.

If you wish to obtain more information about the "scholarship Josefina Garre" and to collaborate with it, you can visit the web page of the initiative.

(source: association Human Management)